COMMUNIQUÉS West-GlobeNewswire

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
16/04/2024
ASPIRE-FTD Sites in the EU and U.S. to Use ClearPoint® Navigation Together With SmartFlow® Cannula for Intrathalamic Gene Therapy Administration SOLANA BEACH, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro [...]
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
16/04/2024
BRISBANE, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating [...]
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
16/04/2024
CONSHOHOCKEN, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced that [...]
Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024
16/04/2024
HAMILTON, Bermuda, April 16, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, April 23, 2024 at 8:30 a.m. Eastern [...]
Sentia Medical Sciences and Neurocrine Biosciences Extend Research Collaboration to Discover Novel CRF Peptides
16/04/2024
SAN DIEGO, April 16, 2024 (GLOBE NEWSWIRE) -- Sentia Medical Sciences Inc. today announced that they have further extended a research collaboration with Neurocrine Biosciences, Inc. (Nasdaq: NBIX) aimed at discovering [...]
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
16/04/2024
BOSTON, April 16, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare [...]
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
16/04/2024
Over 40 solid tumor patients have completed all biomarker testing in the screening protocol; ~60% of these patients qualify for at least one TCR-T in the ImmunoBank and ~30% are eligible for multiplex therapy Patients [...]
Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting
16/04/2024
Long term extension of the Phase 2 VISIONARY-MS clinical trial of CNM-Au8 demonstrated significant evidence of repair and remyelination across multiple paraclinical endpoints (change from original baseline, p<0.05) [...]
Growth of 28% of 2024 first quarter revenue
16/04/2024
Press release Ecully, April 16, 2024 – 8 p.m. First-quarter 2024 revenue of €3.1 million Growth of 28% compared with 2023 first quarter In thousands of euros 2024 2023 Change 2023/2022 Q1 revenue 3,070 2,398 +28% [...]
Croissance de 28% du chiffre d'affaires du 1er trimestre 2024
16/04/2024
Communiqué de presse Ecully, le 16 avril 2024 –20h Chiffre d’affaires du 1 er trimestre 2024 de 3,1 M€ Progression des ventes de + 28% par rapport au 1 er trimestre 2023 En milliers d’euros 2024 2023 Variation en % CA 1 [...]
Pacific Health Care Organization, Inc. Reports its 2023 Year-End Financial Results
16/04/2024
Irvine, April 16, 2024 (GLOBE NEWSWIRE) -- Irvine, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission [...]
CARBIOS wins "So French So Innovative" award at InnoEX 2024, Hong Kong, recognizing French innovation in Asia Pacific
16/04/2024
CARBIOS wins "So French So Innovative" award at InnoEX 2024, Hong Kong, recognizing French innovation in Asia Pacific Clermont-Ferrand, France, Tuesday 16 April 2024 (6.30pm CET) CARBIOS (Euronext Growth Paris: ALCRB), [...]
CARBIOS remporte le prix « So French So Innovative » à l'occasion d’InnoEX 2024, Hong Kong, qui récompense l’innovation française dans la région Asie-Pacifique
16/04/2024
CARBIOS remporte le prix « So French So Innovative » à l'occasion d’InnoEX 2024, Hong Kong, qui récompense l’innovation française dans la région Asie-Pacifique Clermont-Ferrand (France), le mardi 16 avril 2024 (18h30 [...]
Brian Jones of AssureCare Honored with Outstanding Dietitian of the Year Award by Tennessee Academy of Nutrition and Dietetics
16/04/2024
CINCINNATI, April 16, 2024 (GLOBE NEWSWIRE) -- AssureCare , a leading provider of integrated population health management software and a prominent healthcare technology company, is delighted to announce that Brian Jones [...]
Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S
16/04/2024
COPENHAGEN, Denmark, April 16, 2024 – Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following results: The Annual Report for 2023 was adopted. The Board of Directors’ proposal to [...]
OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation Becomes Effective
16/04/2024
OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation Becomes Effective NANTES, France, April 16, 2024 – OSE Immunotherapeutics SA (ISIN: FR0012127173; [...]
OSE Immunotherapeutics annonce l’entrée en vigueur de la licence mondiale pour développer un anticorps monoclonal innovant dans le traitement de l’inflammation chronique
16/04/2024
OSE Immunotherapeutics annonce l’entrée en vigueur de la licence mondiale pour développer un anticorps monoclonal innovant dans le traitement de l’inflammation chronique Nantes, France, le 16 avril 2024, 18 heures – OSE [...]
VIRBAC: Building on the momentum of the second half of 2023, strong first-quarter revenue growth of +10.8% at constant exchange rates
16/04/2024
KEY FIGURES Revenue 1 st quarter 2024 € 345.7 M Growth at constant exchange rates and scope 1 +9.7% of which companion animals +16.2% farm animals +1.2% Growth at constant exchange rates +10.8% Overall change +9.8% 1 [...]
VIRBAC: sur la lancée du second semestre 2023, forte croissance du chiffre d’affaires sur le premier trimestre de +10,8% à taux de change constants
16/04/2024
CHIFFRES CLÉS Chiffre d’affaires 1 er trimestre 2024 345,7 M€ Croissance à taux de change et périmètre constants 1 +9,7% dont animaux de compagnie +16,2% animaux d’élevage +1,2% Croissance à taux de change constants +10 [...]

Pages